Kåre Bergh

Kåre Bergh is affiliated with the Norwegian University of Science and Technology (NTNU), contributing to microbiology and infectious disease research. His work focuses on bacterial infections, biofilm analysis, and antibiotic resistance mechanisms, particularly involving Staphylococcus species and Francisella tularensis. He has published extensively on topics like implant-associated infections, outbreak investigations, and diagnostic methods.

Research interests include orthopedic infections, zoonotic diseases, and molecular epidemiology. His studies span biofilm dynamics, bacterial pathogenesis, and the development of rapid diagnostic protocols using MALDI-TOF MS. Notable contributions include in vivo models of chronic infections and investigations into antibiotic-resistant strains such as vancomycin-variable enterococci.

His articles highlight advancements in understanding Staphylococcus epidermidis biofilm eradication, Borrelia infections in vascular cases, and the role of peptides targeting bacterial replication machinery. Bergh collaborates on projects involving clinical microbiology, genomics, and public health responses to outbreaks like tularaemia.

No scientific awards are explicitly mentioned, but his research has practical implications for infection control and patient care. He has advised on studies related to biofilm sonication, bacterial genotyping, and biomarker development for inflammatory bowel disease.